Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies
Mattioli, G.; Ricci, S.; Menozzi, A.; Teglio, V.
Minerva Cardioangiologica 30(3): 81-88
1982
ISSN/ISBN: 0026-4725 PMID: 6123962 Document Number: 183417
Document emailed within 1 workday
Related Documents
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187Erikssen, J.; Rod, T. 1971: Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 721-725
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Leonetti, G.; Sampieri, L.; Cuspidi, C.; Terzoli, L.; Rupoli, L.; Fruscio, M.; Gradnik, R.; Zanchetti, A. 1985: Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S243-S245
Rostan, A. 1978: Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms Schweizerische Rundschau für Medizin Praxis 67(1): 27-35
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Balansard, P.; Chabrillat, Y.; Paulin, R.; Libes, M.; Gérard, R. 1977: Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension Acta Cardiologica 32(4): 229-243
Wirtzfeld, A.; Klein, G.; Bibra, H.V.; Sauer, E. 1985: Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity? International Journal of Clinical Pharmacology Therapy and Toxicology 23(1): 20-27
Yonga, G.O.; Oyuga, H.W.; Njeru, E.K. 1993: Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise East African Medical Journal 70(7): 405-408
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Schneider, W.; Kaltenback, M. 1988: The use of beta-blockers in unstable angina: comparison with calcium channel blocking agents Journal of Cardiovascular Pharmacology 12(Suppl 1): S78-S82
Strasser, R.; Höltermann, F.P.; von Mengden, H.J. 1986: Echocardiography studies of the relevance and intrinsic activity of beta blockers in the human Medizinische Klinik 81(22): 708-711
Erina, E.V.; Charyev, K.E.; Oshchepkova, E.V. 1983: Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension Kardiologiia 23(4): 53-59
Rosseau, M.; Vandenput, F.; Brasseur, L. 1972: Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICi 50172) in coronary insufficiency. Preliminary results Acta Cardiologica 1972: Suppl 15: 239
Chan, P.S.; Ellenbogen, L. 1974: New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine Archives Internationales de Pharmacodynamie et de Therapie 209(2): 204-213
Mattioli, A.V.; Parato, V.M.; Vivoli, D.; Bergomi, M. 1992: Heart insufficiency treated with beta-blocking agents. Comparison of responders and non-responders Cardiologia 37(5): 337-343
Conde, S.; Corral, C.; Lissavetzky; Darias, V.; Martin, D. 1986: Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol Il Farmaco; Edizione Scientifica 41(1): 80-88
Capodicasa, E.; Corazzi, F.; Romagnoli, M.; de Bellis, F.; Ciaccio, V.; Ficola, F.; Bonifacio, E.; Villa, A. 1994: Leukocyte procoagulant activity and chemotherapeutic agents: comparison between the effects of adriamycin and epiadriamycin on the procoagulant lympho/monocytic activity in vitro Minerva Medica 85(11): 569-577
Gesquière, J.C.; Dhaisne, J.M.; Marcinal-Lefebvre, A.; Bar, D.; Vincent, A.; Dupuis, B. 1982: Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity Annales Pharmaceutiques Francaises 40(3): 251-257
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224